RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKAEMIA
- 23 September 1989
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 334 (8665), 746-747
- https://doi.org/10.1016/s0140-6736(89)90812-x
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 6 references indexed in Scilit:
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Use of differentiation inducing agents in the myelodysplastic syndrome and acute non‐lymphocytic leukemiaAmerican Journal of Hematology, 1988
- EFFECT OF 13-cis-RETINOIC ACID ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROMEThe Lancet, 1987
- Inefficacy of the synthetic aromatic retinoid etretinate and of its free acid on the in-vitro differentiation of leukemic cellsLeukemia Research, 1986
- Discrepancy between in-vitro and in-vivo inductions of differentiation by retinoids of human acute promyelocytic leukemia cells in relapseLeukemia Research, 1985
- Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acidBlood, 1981